Cytokinetics
CYTK
S$47.11
Share price
-1.48%
Change (1 day)
-40.64%
Change (1 year)
Categories
Cytokinetics (CYTK) - Total debt
Total debt on the balance sheet as of March 2025 : S$1.01 Billion
According to Cytokinetics 's latest financial reports the company's total debt is S$1.01 Billion. A company’s total debt is the sum of all current and non-current debts.
Cytokinetics - Total debt on balance sheet (from 2003 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | S$1.07 B | 7.4% |
| 2023-12-31 | S$0.99 B | -0.77% |
| 2022-12-31 | S$1.00 B | 175.64% |
| 2021-12-31 | S$0.36 B | 98.54% |
| 2020-12-31 | S$0.18 B | 0.2% |
| 2019-12-31 | S$0.18 B | 210.94% |
| 2018-12-31 | S$58.99 M | 38.81% |
| 2017-12-31 | S$42.5 M | -1.72% |
| 2016-12-31 | S$43.24 M | 108.85% |
| 2015-12-31 | S$20.7 M | |
| 2012-12-31 | N/A | -100% |
| 2011-12-31 | S$0.19 M | -84.49% |
| 2010-12-31 | S$1.26 M | -92.94% |
| 2009-12-31 | S$17.97 M | 170.85% |
| 2008-12-31 | S$6.63 M | -46.93% |
| 2007-12-31 | S$12.5 M | -24.74% |
| 2006-12-31 | S$16.61 M | 6.59% |
| 2005-12-31 | S$15.58 M | -8.94% |
| 2004-12-31 | S$17.11 M | -0.07% |
| 2003-12-31 | S$17.13 M | 4.01% |
| 2002-12-31 | S$16.47 M | 152.4% |
| 2001-12-31 | S$6.52 M | 248.94% |
| 2000-12-31 | S$1.87 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Ligand Pharmaceuticals LGND | S$5.72 M | -99.44% | 🇺🇸 USA |
 Trevena TRVN | S$48.31 M | -95.25% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | S$0.25 B | -75.23% | 🇺🇸 USA |
 Amgen AMGN | S$73.79 B | 7,153.73% | 🇺🇸 USA |
 Array Technologies ARRY | S$0.87 B | -14.17% | 🇺🇸 USA |